Instruction for use: Parsedil

Dosage form: pill

Active substance: Dipyridamolum

ATX

B01AC07 Dipyridamole

Pharmacological groups

Antiaggregants

Adenosinergic agents

Angioprotectors and microcirculation correctors

The nosological classification (ICD-10)

I50 Heart failure: Exacerbation of chronic heart failure; Shortness of breath with acute heart failure; Acute heart failure; Acute heart failure; Heart failure on the background of intoxication; Heart failure on the background of infections; Acute Heart Failure; Chronic myocardial insufficiency; Cardiac dyspnea

I74 Embolism and arterial thrombosis: Thrombosis of effort (stress); Arterial thrombosis; Arteriothrombosis; Subacute and chronic arterial thrombosis; Subacute thrombosis of peripheral arteries; Postoperative thrombosis; Vascular thrombosis; Vascular embolism; Thrombosis of aortocoronary shunt; Arterial thrombosis; Thrombosis of arteries; Coronary artery thrombosis; Coronary thrombosis; Thrombosis of blood vessels; Thrombosis with ischemic stroke; Thrombosis with general surgical operations; Thrombosis in Oncology Operations; Vascular thrombosis; Thrombus formation in the postoperative period; Thrombotic complications; Thromboembolic diseases; Thromboembolic syndrome; Thromboembolic complication in the postoperative period; Thromboembolism of arteries; Partial vascular thrombosis; Embolism; Embolism of arteries

I82 Embolism and thrombosis of other veins: Recurrent venous thrombosis; Postoperative thrombosis; Venous thrombosis; Acute venous thromboembolism; Recurrent vein thrombosis; Venous thrombosis; Thrombosis of veins of internal organs; Venous thrombosis; Deep vein thrombosis; Thrombosis of blood vessels; Vascular thrombosis; Thrombosis of veins; Deep vein thrombosis; Thromboembolic diseases; Thromboembolism of veins; Severe venous thrombosis; Embolism; Embolism of veins; Thromboembolic complications

Structure and Composition

1 dragee contains dipyridamole 75 mg; In blistere 15 pcs., In a cardboard box 1 blister.

Pharmachologic effect

Mode of action - Vasodilator, antiaggregational, antiadhesive, arteriodilating.

Inhibits phosphodiesterase, increases cAMP content in endothelial cells, thrombocytes, reduces aggregation and adhesion of the latter, improves microcirculation and oxygen supply to the myocardium.

Indications of the drug Parsedil

Thrombosis, thromboembolic complications (prevention and treatment), chronic heart failure.

Contraindications

Hypersensitivity, acute myocardial infarction.

Pregnancy and breast-feeding

With caution in the 2nd and 3rd trimester of pregnancy.

Side effects

Headache, tachycardia, gastralgia, dyspeptic disorders.

Dosing and Administration

Inside, on an empty stomach, 1 hour before meals. For prophylaxis and therapy of thromboembolic complications or with simultaneous administration with acetylsalicylic acid - 75 mg 3 times a day.

Storage conditions of the drug Parsedil

In dry, the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

The shelf life of the drug Parsedil

5 years.

Do not use beyond the expiration date printed on the package.